HKD 1.28
(4.92%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -74.31 Million USD | 8.0% |
2022 | -80.77 Million USD | 58.96% |
2021 | -196.83 Million USD | 44.57% |
2020 | -355.06 Million USD | -1027.81% |
2019 | -31.48 Million USD | 44.91% |
2018 | -57.14 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -118.08 Million USD | 1.04% |
2024 Q1 | -118.08 Million USD | -58.9% |
2023 Q2 | -96.29 Million USD | 1.03% |
2023 Q1 | -97.29 Million USD | -20.45% |
2023 Q4 | -74.31 Million USD | 1.16% |
2023 FY | -74.31 Million USD | 8.0% |
2023 Q3 | -75.18 Million USD | 21.92% |
2022 Q2 | -141.09 Million USD | 1.8% |
2022 FY | -80.77 Million USD | 58.96% |
2022 Q4 | -80.77 Million USD | 1.58% |
2022 Q3 | -82.07 Million USD | 41.83% |
2022 Q1 | -143.68 Million USD | 27.0% |
2021 Q4 | -196.83 Million USD | 1.3% |
2021 Q1 | -277.54 Million USD | 21.83% |
2021 Q2 | -275.7 Million USD | 0.66% |
2021 Q3 | -199.42 Million USD | 27.67% |
2021 FY | -196.83 Million USD | 44.57% |
2020 FY | -355.06 Million USD | -1027.81% |
2020 Q4 | -355.06 Million USD | 0.41% |
2020 Q3 | -356.51 Million USD | -307.88% |
2020 Q2 | -87.4 Million USD | -139.27% |
2020 Q1 | 222.56 Million USD | 806.94% |
2019 Q1 | 61.15 Million USD | 0.0% |
2019 Q3 | 169.64 Million USD | 0.0% |
2019 Q4 | -31.48 Million USD | -118.56% |
2019 FY | -31.48 Million USD | 44.91% |
2018 FY | -57.14 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | -76.36 Million HKD | 2.694% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 101.411% |